Text Message Reminders for Influenza Vaccine in Pregnancy

Completed

• Conditions: Pregnancy

• Registration Number: NCT02428738
• Lead Sponsor: Unity Health Toronto

Brief Summary

Influenza virus accounts for numerous cases (epidemics) of respiratory illnesses each year worldwide and affects people of all ages. These epidemics typically occur in the winter months, and can result in substantial morbidity and mortality in persons at risk. Pregnant women may be more susceptible to morbidity and mortality associated with influenza infection. This increased risk may result from several factors including increased heart rate, stroke volume, and oxygen consumption, decreased lung capacity, and changes in immunologic function. Immunization of women during pregnancy can help to prevent infection in the woman herself and may also offer protection to the infant in two ways: by the passage of antibodies from mother to the fetus during pregnancy, and by preventing infection in the mother and therefore decreasing the infant's exposure risk after birth. In Canada, the National Advisory Committee on Immunization (NACI) recommends the vaccine for pregnant women who are expected to deliver during influenza season because they will become household contacts of their newborn. Ideal timing of vaccination occurs in October or November since influenza outbreaks typically occur throughout the winter months. Despite the Canadian and American guidelines for influenza vaccination during pregnancy, it is unclear how many women are offered and/or actually receive the vaccine while pregnant. There is, however, evidence that women will accept the vaccine if offered. Specifically, in the Women's Health Care Centre at St. Michael's Hospital, it was found that 42% of women not only accepted but also received the influenza vaccination when offered. Innovative techniques will be required to continue to increase vaccination rates among vulnerable populations, including pregnant women. The purpose of the present study is to determine if the use of electronic reminders (text messages) increases the likelihood of receiving the influenza vaccine among pregnant women.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-11
• Primary Completion: 2014-01
• Study Completion: 2014-03
• Study First Submitted: 2015-04-16
• Study First Submitted QC: 2015-04-23
• Study First Posted: 2015-04-29
• Status Verified: 2019-02
• Last Update Submitted: 2019-02-20
• Last Update Posted: 2019-02-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 317

Inclusion Criteria

• Pregnant Woman
• Ages 18 and over
• Working cellular telephone with the ability to receive text messages
• Ability to speak or understand English

Exclusion Criteria

• Age less than 18
• Inability to speak or understand English
• Not possessing a working cellular telephone with text messaging capability
• Presence of any contraindications to vaccination (such as egg allergy or prior adverse reaction to the vaccine)
• Women who have already received the vaccine during this influenza season

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of Influenza Vaccination of those who do receive text message reminders compared to those who do not.	Up to 5 months	To determine the percentage of women who receive the influenza vaccine during pregnancy and also received text message reminders, relative to women who do not receive text messages.

Secondary Outcome Measures

Name	Time	Method
Patient characteristics affecting liklihood of receiving vaccine	Up to 5 months	Patient characteristics (e.g. race/ethnicity, education level, family income, number of prior pregnancies, history of receiving the vaccine in the past) affecting the likelihood of receiving the vaccine among those who receive reminders.

Trial Locations

Locations (1)

St. Michael's Hospital; 🇨🇦 Toronto, Ontario, Canada